Key Performance
More- Earnings Score: 89
- Momentum Score: 71
- True Yield: N/A
- Financial Health Score: 100
%20scale(1,1)}%2025%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(1,1)}}%20%23ewMkZ6d8Hun3_ts%20{animation:%20ewMkZ6d8Hun3_ts__ts%204000ms%20linear%20infinite%20normal%20forwards}@keyframes%20ewMkZ6d8Hun3_ts__ts%20{%200%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}%2025%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}}%20]]%3e%3c/style%3e%3cdefs%3e%3clinearGradient%20id='ewMkZ6d8Hun2-fill'%20x1='12.5'%20y1='23.5001'%20x2='-0.868518'%20y2='16.4047'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun2-fill-0'%20offset='0%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun2-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3clinearGradient%20id='ewMkZ6d8Hun3-fill'%20x1='31.5059'%20y1='27.1026'%20x2='10.2884'%20y2='14.9373'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun3-fill-0'%20offset='4.7%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun3-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3c/defs%3e%3cg%20id='ewMkZ6d8Hun2_ts'%20transform='translate(24.943161,19.954806)%20scale(1,1)'%3e%3cpath%20d='M14.8466,29.2814c0,0-14.408088-4.6983-12.05895-19.79995c0,0,1.50345,4.85085,4.13448,5.30845s-2.03592,4.6373,7.92447,14.4915Z'%20transform='translate(-24.943161,-19.954806)'%20fill='url(%23ewMkZ6d8Hun2-fill)'/%3e%3c/g%3e%3cg%20id='ewMkZ6d8Hun3_ts'%20transform='translate(24.9787,20.012362)%20scale(1,1)'%3e%3cpath%20d='M37.4922,21.9282l4.0719.244v-12.81353C31.0713,3.28748,17.7595,7.6502,17.7595,7.6502c.3445-4.51526-3.5707-5.52204-3.5707-5.52204c2.5371,1.52542.3132,6.22373.3132,6.22373C13.0299,0.084092,0,1.02986,0,1.02986C8.92672,4.35528,6.70287,7.98579,6.8908,16.6197c.18794,8.6034,8.3943,12.9966,8.3943,12.9966l-6.60895-.2441v13.2407c0,0,5.48135,2.3797,13.68765,3.1729v-22.3017h-4.4477c-1.0023,0-1.942-.8237-1.942-1.8v-5.7356c0-.9763.9397-1.8,1.942-1.8h4.4477v-1.3424h5.0115v1.3424h5.0115c1.0023,0,1.848.7932,1.848,1.8v5.7356c0,.9763-.8144,1.8-1.848,1.8h-5.0115v22.5153h.2819c11.1192-.0611,15.9428-7.3221,16.256-13.3017.4698-7.7492-6.421-10.7695-6.421-10.7695Z'%20transform='translate(-24.9787,-20.012361)'%20fill='url(%23ewMkZ6d8Hun3-fill)'/%3e%3c/g%3e%3c/svg%3e)
Latest Research & News
Tactile Medical Strengthens Board of Directors with Appointment of Andrea Pearson
Tactile Systems Technology, Inc. (Nasdaq: TCMD) announced the appointment of Andrea Pearson to its Board of Directors effective March 9, 2026. Pearson is an experienced healthcare executive with over 25 years in the industry, most recently serving as Growth Advisor and Chief Marketing Officer at Harbor Health. She previously held senior roles at DispatchHealth and HealthGrades, where she demonstrated strong track records in scaling businesses and driving revenue growth.
03/09/2026, 8:00 AM • GlobeNewswire
U.S. stock futures rose on Wednesday with the Dow Jones, S&P 500, and Nasdaq 100 all posting gains. Investors await January FOMC minutes and Friday's PCE index release. Key movers include Ovintiv surging 4.17% after announcing a $3 billion asset sale, Tactile Systems jumping 23.53% on strong guidance, Celanese rising 5.94% despite earnings miss, and Palo Alto Networks falling 7.34% after lowering profit guidance.
02/18/2026, 8:38 AM • Benzinga
Tactile Systems Stock Smashes 52-Week High After Strong Quarter
Tactile Systems Technology (NASDAQ: TCMD) surged 23.35% in premarket trading to a new 52-week high following strong fourth-quarter earnings and the acquisition of LymphaTech. The company reported Q4 EPS of 46 cents (beating consensus of 44 cents) and sales of $103.59 million (up 21%, exceeding estimates of $93.80 million). The $6.8 million acquisition is expected to enhance lymphedema treatment capabilities. For fiscal 2026, the company forecasts sales of $357-$365 million and adjusted EBITDA of $49-$51 million, both above consensus expectations.
02/18/2026, 6:15 AM • Benzinga
U.S. stock futures rose on Wednesday with the Dow Jones, S&P 500, and Nasdaq 100 all posting gains. Investors await January FOMC minutes and Friday's PCE index release. Key movers include Ovintiv surging 4.17% after announcing a $3 billion asset sale, Tactile Systems jumping 23.53% on strong guidance, Celanese rising 5.94% despite earnings miss, and Palo Alto Networks falling 7.34% after lowering profit guidance.
02/18/2026, 4:59 AM • Benzinga
Tactile Systems Technology Inc. (NASDAQ: TCMD) has acquired LymphaTech Inc. for $6.8 million upfront plus potential milestone-based payments. LymphaTech's 3D digital measurement platform for lymphedema assessment will expand Tactile Medical's lymphedema portfolio, enabling more accurate disease identification and progression monitoring. The acquisition positions Tactile Medical as a comprehensive solutions leader for lymphatic dysfunction.
02/17/2026, 4:04 PM • Benzinga
3 Small Caps Drawing Insider and Institutional Support
The article highlights three small-cap stocks with potential for growth in 2025, focusing on insider and institutional buying amid improving macroeconomic conditions and potential interest rate cuts.
07/14/2025, 12:31 PM • Investing
Peers
Statistics
MoreInformation as of 06/02/2026
Company Profile
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.